<DOC>
	<DOCNO>NCT01013376</DOCNO>
	<brief_summary>The safety comfort repeat administration topically-administered ophthalmic formulation MC-1101 establish investigator assessment subject report 3 day period . Safety assessment perform normal , healthy subject well sign symptom early non-exudative age-related macular degeneration ( dry AMD ) .</brief_summary>
	<brief_title>A Pilot Study Safety MC-1101 Both Normal Volunteers Patients With Early Dry AMD</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Clinical diagnosis dry AMD ; Normal , healthy volunteer Uncontrolled systemic disease Women pregnant , nursing , plan pregnancy study 's duration</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>